Raymond James & Associates Charles River Laboratories International, Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 249,037 shares of CRL stock, worth $28.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
249,037
Previous 248,112
0.37%
Holding current value
$28.8 Million
Previous $51.3 Million
4.29%
% of portfolio
0.03%
Previous 0.03%
Shares
29 transactions
Others Institutions Holding CRL
# of Institutions
699Shares Held
50.7MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$713 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$589 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$253 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$209 Million0.79% of portfolio
-
Allspring Global Investments Holdings, LLC1.77MShares$205 Million0.5% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $5.89B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...